Recombinant Human HLA-A*11:01&B2M&HPV16 E7 (IVCPICSQK) Monomer Protein
Beta LifeScience
SKU/CAT #: BLK-00125P-100UG

Human HLA-A*11:01&B2M&HPV16 E7 (IVCPICSQK) Monomer on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human HLA-A*11:01&B2M&HPV16 E7 (IVCPICSQK) Monomer Protein
Beta LifeScience
SKU/CAT #: BLK-00125P-100UG
Collections: Fc receptors, Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human HLA-A*11:01&B2M&HPV16 E7 (IVCPICSQK) Monomer Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Gly25-Thr305 (HLA-A*11:01), Ile21-Met119 (B2M) and IVCPICSQK peptide. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | AAV53343.1(HLA-A*11:01)&P61769(B2M)&IVCPICSQK |
Target Symbol | HLA-A*11:01&B2M&HPV16 E7 (IVCPICSQK) Monomer |
Species | Human |
Expression System | HEK293 |
Tag | C-His-Avi |
Expression Range | Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and IVCPICSQK peptide |
Mol. Weight | The protein has a predicted MW of 50.39 kDa. Due to glycosylation, the protein migrates to 52-62 kDa based on Tris-Bis PAGE result. |
Form | Liquid |
Formulation | Supplied as 0.22 um filtered solution in PBS (pH 7.4). |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Shipping | Shipped with dry ice. |
Gene Background | HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. |